Core Viewpoint - Sichuan Province is actively promoting the HPV vaccine through various initiatives aimed at improving public health, including expanding the target population, reducing vaccine costs, and optimizing service processes [1][2][3] Group 1: HPV Vaccine Promotion - The HPV vaccination program will begin in 2025 across several cities and counties in Sichuan, with specific measures such as extending the vaccination period and providing cost reductions for certain age groups [1] - Eligible individuals aged 9-26 years and 35-45 years for females, as well as 16-26 years for males, can receive a cost reduction for the final dose of the imported nine-valent HPV vaccine [1][2] - The vaccination schedule for girls aged 9-14 allows for a two-dose regimen where the first dose is charged and the second dose is free [1] Group 2: Health Impact and Statistics - The incidence of cervical cancer in China has been rising, with nearly 150,000 new cases and 60,000 deaths reported in 2022, highlighting the importance of preventive measures [2] - The World Health Organization emphasizes that cervical cancer is preventable, and the 2023 guidelines recommend health education and HPV vaccination as primary prevention strategies [2] Group 3: Guidelines and Recommendations - The "Clinical Application Guidelines for Preventive HPV Vaccines in China (2025 Edition)" recommend prioritizing HPV vaccination for females aged 9-26, particularly focusing on girls aged 9-14 [3] - The initiatives in Sichuan reflect a commitment to implementing scientific recommendations and aim to establish a herd immunity barrier by including males and other age groups in the vaccination program [3] - The policies are designed to enhance public willingness to vaccinate by lowering costs and improving service accessibility, with extended service periods and appointment windows [3]

Core Viewpoint - Jiangsu Province is implementing HPV vaccination initiatives to enhance public health and prevent cervical cancer, aligning with national health strategies and local action plans [1][2]. Group 1: HPV Vaccination Initiatives - Starting in 2023, Jiangsu Province has included "free HPV vaccination for eligible girls" in its government welfare projects for three consecutive years, targeting first-year middle school girls [2]. - Various cities in Jiangsu are offering financial incentives for HPV vaccinations, significantly reducing economic burdens and increasing vaccination willingness among the population [2]. - The vaccination program has expanded to include women aged 9-26 and men aged 16-26, with specific financial incentives for receiving the imported nine-valent HPV vaccine [2][3]. Group 2: Health Statistics and Trends - HPV infection is common, with high-risk types causing approximately 98% of cervical cancer cases in Chinese women, highlighting the importance of early vaccination [4]. - The incidence of cervical cancer in China is rising, with nearly 150,000 new cases and 60,000 deaths reported in 2022, indicating a need for preventive measures [4]. - The age distribution of HPV infections shows peaks at 17-24 years and 40-44 years, emphasizing the necessity of vaccination across different age groups [5]. Group 3: Broader Health Implications - HPV is not exclusive to women; men also face significant health risks, with a lifetime infection rate of about 90%, which can lead to various cancers [5][6]. - Joint vaccination strategies for both genders can significantly reduce HPV infection rates and associated healthcare costs, facilitating the goal of cervical cancer elimination [6]. Group 4: Accessibility and Public Awareness - The vaccination program aims to create a robust immunity barrier by including diverse age groups and genders, thus promoting community health [7]. - Local vaccination policies have varying deadlines, and eligible individuals are encouraged to consult local health services to plan their vaccinations effectively [3][7].

4月25日是全国儿童预防接种宣传日，今年的宣传主题为"打疫苗 防疾病 保健康"。疫苗不仅是保护个体 的有效手段，更是构建群体免疫屏障的关键一环。但生活中，不少人对疫苗有颇多误解。什么是一类疫 苗、二类疫苗？二类疫苗要不要打？患过敏性疾病患者不能接种疫苗？如何选择进口疫苗、国产疫苗？ 我们请专家来解答。 【科普专家】 清华大学第一附属医院预防保健科主任 刘兆秋 北京儿童医院顺义妇儿医院儿科医生 赵佳伟 北京中医药大学东方医院儿科主治医师 马佳 Q：疫苗是如何被发现的？ A：1796年，英国医生爱德华·琴纳通过接种牛痘成功预防了天花的发生，人类首次掌握对抗传染病的有 力武器。此后，疫苗的发展成为照亮人类前行的曙光，1885年路易·巴斯德研发出狂犬病疫苗，20世纪 脊髓灰质炎疫苗问世。 Q：什么是一类、二类疫苗？ A：一类疫苗是由国家规定的、国家免费提供的疫苗，公民应当依照政府的规定接种。二类疫苗则是个 人根据自身意愿和经济能力，自费选择接种的疫苗。 Q：一类、二类疫苗是独立的吗？ A：免疫系统是通过对病毒的辨识来产生抗体的，疫苗的作用仅仅是代替病毒去刺激人的免疫系统而 已。同一种病毒，在全世界都是一样的，不存在" ...